Skip to main content
. 2015 Jun 22;6(28):24722–24732. doi: 10.18632/oncotarget.4406

Table 2. Univariate and multivariate analysis of the relative risks for recurrence-free survival in HCC.

Variables Univariate analysis Multivariate analysis
Relative risk 95% CI P Relative risk 95% CI P
Age (>70 years) 1.432 0.873–2.347 0.1547 1.758 0.744–4.155 0.2006
Sex (male) 1.779 0.898–3.524 0.0986 2.371 0.807–6.966 0.1182
Liver cirrhosis 1.147 0.695–1.895 0.5920
HBV infection 0.949 0.563–1.597 0.8425
HCV infection 1.439 0.890–2.328 0.1378 2.457 1.058–5.707 0.0375
V (+) 1.299 0.824–2.048 0.2608
Tumor size (>30 mm) 1.539 0.951–2.489 0.0793 1.503 0.619–3.649 0.3701
Pathology (contain por) 0.446 0.165–1.199 0.1095 0.413 0.108–1.578 0.1981
Stage (≥3) 1.318 0.840–2.067 0.2297
ALDH1A1 high expression 0.739 0.471–1.158 0.1862 0.871 0.344–2.203 0.7714
AFP (>100 ng/ml) 1.364 0.877–2.119 0.1681 3.502 1.332–9.203 0.0114
Albumin (≥3.5 g.dl) 1.143 0.672–1.944 0.6221
Platelets (≥15 × 104/μl) 1.019 0.644–1.612 0.9376
Total bilirubin (≥1.0 mg/dl) 1.125 0.686–1.846 0.6412

Statistically significant values are displayed in boldface.

Abbreviations: HCC, hepatocellular carcinoma; CI, confidence interval; HBV, hepatitis B virus; HCV, hepatitis C virus; V, lymphovascular invasion; por, poorly differentiated; AFP, α-fetoprotein.